Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aera Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aera Therapeutics

Aera Therapeutics

Series B

Aera Therapeutics: A biotech firm enhancing genetic medicines' potential with proprietary protein nanoparticle delivery tech.

HQ
Boston, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Aera Therapeutics, founded with a mission to unlock the full potential of genetic medicines, leverages its proprietary protein nanoparticle (PNP) delivery platform to overcome the limitations of current delivery technologies. The company's innovative platform, based on endogenous human proteins, aims to extend the reach of genetic medicines to various tissues and applications, thereby benefiting a broader range of patients across multiple disease areas.

Notable affiliated individuals and investors include leading figures in biotechnology and venture capital. Aera Therapeutics has achieved significant milestones in advancing its PNP delivery technology, positioning itself as a key player in the genetic medicine landscape. The company's impact is marked by its potential to transform therapeutic approaches and improve patient outcomes in diverse medical fields.

Aera Therapeutics - Similar Companies

Aro Biotherapeutics logo

Aro Biotherapeutics

arobiotx.com

Affinia Therapeutics logo

Affinia Therapeutics

affiniatx.com

Alaya.bio logo

Alaya.bio

alaya.bio

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Kelonia Therapeutics logo

Kelonia Therapeutics

keloniatx.com

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Lattice Therapeutics logo

Lattice Therapeutics

Alltrna logo

Alltrna

alltrna.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Frontera Therapeutics logo

Frontera Therapeutics

Orna Therapeutics logo

Orna Therapeutics

Aer Therapeutics logo

Aer Therapeutics

Phoreus Biotechnology logo

Phoreus Biotechnology

phoreusbiotech.com

Faze Medicines logo

Faze Medicines

fazemed.com

Aera Therapeutics - Quick Facts

Who are Aera Therapeutics' competitors?

Companies similar to Aera Therapeutics include Aro Biotherapeutics, Affinia Therapeutics, Alaya.bio and ReviR Therapeutics.

When was Aera Therapeutics founded?

Aera Therapeutics was founded in 2021.

Where is Aera Therapeutics' headquarters located?

Aera Therapeutics' headquarters is located in Boston, MA, US.

When was Aera Therapeutics' last funding round?

Aera Therapeutics' most recent funding round was for $193M (USD) in February 2023.

How much has Aera Therapeutics raised to-date?

As of Feb 16, 2023, Aera Therapeutics has raised a total of $193M (USD).

How many employees does Aera Therapeutics have?

Aera Therapeutics has 175 employees as of Feb 4, 2024.

Aera Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Main Product
  • Genetic Medicines
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified